The Greater Cannabis Company, Inc. (OTC:GCAN)
Industry: Drug Manufacturers - Specialty & Generic

OFF LIST - 2658 consecutive market days: OFF LIST as of 11/11/2005 Through 11/14/2016

The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson's disease, Alzheimer's disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.

Current Quote*
Last: $0.000
Change: 0.000
Book: $Unk
Volume: 5,259,508

As Of: 07/03 16:10 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol GCAN

  • No BuyIns.Net Alerts Available for GCAN

Graphs for GCAN


3 Month Graph


6 Month Graph


1 Year Graph